MPM
IBB icon

MBB Public Markets’s iShares Biotechnology ETF IBB Stock Holding History

MBB Public Markets’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,220
Closed -$4.01M – 706
2024
Q1 		$4.01M Sell
29,220
-137,473
-82% -$18.8M 0.25% 58
2023
Q4 		$22.6M Sell
166,693
-76,700
-32% -$9.36M 1.39% 25
2023
Q3 		$29.8M Hold
243,393
– – 1.8% 20
2023
Q2 		$30.9M Buy
243,393
+3,693
+2% +$480K 1.62% 20
2023
Q1 		$31M Sell
239,700
-13,632
-5% -$1.78M 1.72% 19
2022
Q4 		$33.3M Sell
253,332
-24,555
-9% -$3.17M 0.9% 15
2022
Q3 		$32.5M Hold
277,887
– – 0.85% 14
2022
Q2 		$32.7M Buy
277,887
+85,865
+45% +$10.2M 0.77% 12
2022
Q1 		$25M Buy
192,022
+179,168
+1,394% +$23.3M 0.52% 12
2021
Q4 		$1.96M Buy
+12,854
New +$1.99M 0.04% 68

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

MBB Public Markets's IBB Position: Q2 2024 in Review

MBB Public Markets sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 29,220 shares — an estimated $4.01M sold.

MBB Public Markets first reported a position in IBB in Q4 2021 and held it in 10 quarters. The position peaked at $33.3M in Q4 2022. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

  • MBB Public Markets reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
  • MBB Public Markets sold 29,220 iShares Biotechnology ETF shares in Q2 2024, an estimated $4.01M.
  • MBB Public Markets first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 10 quarters.
  • MBB Public Markets's iShares Biotechnology ETF position peaked at $33.3M in Q4 2022.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on MBB Public Markets's 13F filing for Q2 2024, filed 14 Aug 2024.